Live feed
Filing
SC 13D/A
SC 13D/A0001213900-23-076489·NeuBase Therapeutics, Inc.
Schedule 13D ownership disclosure
NEUBASE THERAPEUTICS INC
Security class unavailable · CUSIP: 64132K201
Event date: 2023-09-08
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 472,926
- Percent of class
- 9.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-23-076489
- Form type
- SC 13D/A
- Filer
- NeuBase Therapeutics, Inc.
- CIK
- CIK 1173281
- Filed
- Sep 14, 2023
- Reporting period
- Sep 08, 2023
- Description
- Schedule 13D beneficial ownership